Metrodora Institute | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Metrodora Institute

PRESS RELEASE

published on 01/18/2024 at 17:00, 10 months 2 days ago

Metrodora Foundation Announces New Scientific Advisory Board
The Metrodora Foundation has announced the formation of a new Scientific Advisory Board (SAB) comprised of leading experts in life sciences, clinical research, technology, and industry. The SAB will provide strategic guidance to accelerate critical research for patients living with chronic, multisystem disorders such as Long-Covid, ME/CFS, POTS, and others. The Foundation aims to catalyze scientific collaboration and discovery to find new diagnostics, treatments, and cures for these complex conditions. The esteemed group of scientific thought leaders collaborating with Metrodora will work towards understanding the biological drivers of these underserved conditions and improving patient outcomes.

Metrodora Foundation Scientific Advisory Board Chronic Multisystem Disorders Patient Outcomes Scientific Collaboration
PRESS RELEASE

published on 01/05/2024 at 15:00, 10 months 15 days ago

Metrodora Institute Announces New Chief Scientific Officer
Metrodora Institute, a leading multispecialty healthcare institute, announces the hiring of Rohit Gupta, a nationally recognized scientist, biobank, and data expert, as its new Chief Scientific Officer and Head of R&D. Gupta's extensive experience and expertise in leading research enterprises and developing innovative medical technology make him a valuable addition to the institute. His vision and leadership will accelerate Metrodora's goals of developing and adopting new solutions to improve the lives of the patients they serve. Located in Salt Lake City, Utah, Metrodora Institute was founded in 2021 with the vision of reimagining care for patients with complex multisystem disorders, treating neurological, gastrointestinal, immunological, autoimmune, pain, and metabolic disorders.

Metrodora Institute Rohit Gupta Chief Scientific Officer Biobank Multispecialty Healthcare
PRESS RELEASE

published on 12/13/2023 at 15:00, 11 months 7 days ago

Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer

Accesswire

Published on 11/21/2024 at 10:03, 41 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 44 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 44 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 9 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 19 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 14 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 39 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 42 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 44 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 44 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 46 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 24 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 59 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 59 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE